Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Xu, Xiyan"" wg kryterium: Autor


Tytuł :
Integrating genotypes and phenotypes improves long-term forecasts of seasonal influenza A/H3N2 evolution.
Autorzy :
Huddleston J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, United States.; Molecular and Cell Biology Program, University of Washington, Seattle, United States.
Barnes JR; Virology Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), Atlanta, United States.
Rowe T; Virology Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), Atlanta, United States.
Xu X; Virology Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), Atlanta, United States.
Kondor R; Virology Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), Atlanta, United States.
Wentworth DE; Virology Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), Atlanta, United States.
Whittaker L; WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, London, United Kingdom.
Ermetal B; WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, London, United Kingdom.
Daniels RS; WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, London, United Kingdom.
McCauley JW; WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, London, United Kingdom.
Fujisaki S; Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Nakamura K; Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Kishida N; Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Watanabe S; Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Hasegawa H; Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Barr I; The WHO Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Subbarao K; The WHO Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Barrat-Charlaix P; Biozentrum, University of Basel, Basel, Switzerland.; Swiss Institute of Bioinformatics, Basel, Switzerland.
Neher RA; Biozentrum, University of Basel, Basel, Switzerland.; Swiss Institute of Bioinformatics, Basel, Switzerland.
Bedford T; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, United States.
Pokaż więcej
Źródło :
ELife [Elife] 2020 Sep 02; Vol. 9. Date of Electronic Publication: 2020 Sep 02.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Genotype*
Phenotype*
Influenza A Virus, H3N2 Subtype/*genetics
Influenza, Human/*virology
Forecasting ; Humans ; Seasons
Czasopismo naukowe
Tytuł :
Update: Influenza Activity in the United States During the 2018-19 Season and Composition of the 2019-20 Influenza Vaccine.
Autorzy :
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Elal AIA; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Alabi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Biggerstaff M; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Budd AP; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Burns E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Cummings CN; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garg S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kondor R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Nyanseor S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
O'Halloran A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Rolfes M; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Sessions W; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Dugan VG; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Stevens J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jernigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Pokaż więcej
Źródło :
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2019 Jun 21; Vol. 68 (24), pp. 544-551. Date of Electronic Publication: 2019 Jun 21.
Typ publikacji :
Journal Article
MeSH Terms :
Population Surveillance*
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Antiviral Agents/pharmacology ; Child ; Child Mortality ; Child, Preschool ; Cost of Illness ; Drug Resistance, Viral ; Hospitalization/statistics & numerical data ; Humans ; Infant ; Infant Mortality ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza Vaccines/administration & dosage ; Influenza Vaccines/chemistry ; Influenza, Human/mortality ; Influenza, Human/prevention & control ; Influenza, Human/virology ; Middle Aged ; Outpatients/statistics & numerical data ; Pneumonia/mortality ; Seasons ; Severity of Illness Index ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Update: Influenza Activity - United States, September 30, 2018-February 2, 2019.
Autorzy :
Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Dugan VG; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Abd Elal AI; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Alabi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Budd AP; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Burns E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Cummings CN; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garg S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garten R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kramer N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
O'Halloran A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Reed C; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Rolfes M; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Sessions W; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Taylor C; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Katz J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jernigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Pokaż więcej
Źródło :
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2019 Feb 15; Vol. 68 (6), pp. 125-134. Date of Electronic Publication: 2019 Feb 15.
Typ publikacji :
Journal Article
MeSH Terms :
Population Surveillance*
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Child ; Child Mortality ; Child, Preschool ; Drug Resistance, Viral ; Hospitalization/statistics & numerical data ; Humans ; Infant ; Infant Mortality ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza Vaccines/chemistry ; Influenza, Human/mortality ; Influenza, Human/prevention & control ; Influenza, Human/virology ; Middle Aged ; Outpatients/statistics & numerical data ; Pneumonia/mortality ; Prevalence ; Seasons ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Update: Influenza Activity in the United States During the 2017-18 Season and Composition of the 2018-19 Influenza Vaccine.
Autorzy :
Garten R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Elal AIA; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Alabi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Biggerstaff M; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Budd AP; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Burns E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Cummings CN; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Davis T; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garg S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jang Y; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kramer N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Lindstrom S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Mustaquim D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
O'Halloran A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Sessions W; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Taylor C; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Dugan VG; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Katz J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jernigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Pokaż więcej
Źródło :
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2018 Jun 08; Vol. 67 (22), pp. 634-642. Date of Electronic Publication: 2018 Jun 08.
Typ publikacji :
Journal Article
MeSH Terms :
Population Surveillance*
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Child ; Child Mortality ; Child, Preschool ; Drug Resistance, Viral ; Hospitalization/statistics & numerical data ; Humans ; Infant ; Infant Mortality ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza Vaccines/chemistry ; Influenza, Human/mortality ; Influenza, Human/prevention & control ; Influenza, Human/virology ; Middle Aged ; Outpatients/statistics & numerical data ; Pneumonia/mortality ; Seasons ; Severity of Illness Index ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Update: Influenza Activity - United States, October 1, 2017-February 3, 2018.
Autorzy :
Budd AP; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Elal AIA; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Alabi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Burns E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Cummings CN; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Davis T; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Flannery B; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garg S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garten R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jang Y; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kramer N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Lindstrom S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Mustaquim D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
O'Halloran A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Olsen SJ; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Sessions W; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Taylor C; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Dugan VG; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Katz J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jernigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Pokaż więcej
Źródło :
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2018 Feb 16; Vol. 67 (6), pp. 169-179. Date of Electronic Publication: 2018 Feb 16.
Typ publikacji :
Journal Article
MeSH Terms :
Population Surveillance*
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Ambulatory Care/statistics & numerical data ; Antiviral Agents/pharmacology ; Child ; Child Mortality ; Child, Preschool ; Drug Resistance, Viral ; Female ; Hospitalization/statistics & numerical data ; Humans ; Infant ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza, Human/mortality ; Influenza, Human/virology ; Male ; Middle Aged ; Pneumonia/mortality ; Pregnancy ; Seasons ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Update: Influenza Activity - United States, October 1-November 25, 2017.
Autorzy :
Dugan VG; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Elal AIA; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Alabi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Burns E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Cummings CN; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Davis T; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Flannery B; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garg S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garten R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jang Y; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kramer N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Lindstrom S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Mustaquim D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
O'Halloran A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Olsen SJ; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Sessions W; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Taylor C; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Trock S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Katz J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jernigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Pokaż więcej
Źródło :
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2017 Dec 08; Vol. 66 (48), pp. 1318-1326. Date of Electronic Publication: 2017 Dec 08.
Typ publikacji :
Journal Article
MeSH Terms :
Disease Outbreaks*
Population Surveillance*
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H1N2 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Child ; Child Mortality ; Child, Preschool ; Drug Resistance, Viral ; Hospitalization/statistics & numerical data ; Humans ; Infant ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H1N2 Subtype/drug effects ; Influenza A Virus, H1N2 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza, Human/mortality ; Influenza, Human/virology ; Middle Aged ; Outpatients/statistics & numerical data ; Pneumonia/epidemiology ; Pneumonia/mortality ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Update: Influenza Activity - United States and Worldwide, May 21-September 23, 2017.
Autorzy :
Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Alabi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Azziz-Baumgartner E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Burns E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Davis CT; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Dugan VG; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garten R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Grohskopf LA; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Lindstrom S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Mustaquim D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Olsen SJ; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Roguski K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Taylor C; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Trock S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Katz J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jernigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Pokaż więcej
Źródło :
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2017 Oct 06; Vol. 66 (39), pp. 1043-1051. Date of Electronic Publication: 2017 Oct 06.
Typ publikacji :
Journal Article
MeSH Terms :
Disease Outbreaks*
Population Surveillance*
Global Health/*statistics & numerical data
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Centers for Disease Control and Prevention, U.S. ; Humans ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/genetics ; Seasons ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Effect of Priming With Seasonal Influenza A(H3N2) Virus on the Prevalence of Cross-Reactive Hemagglutination-Inhibition Antibodies to Swine-Origin A(H3N2) Variants.
Autorzy :
Liu F; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Veguilla V; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Gross FL; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Gillis E; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Rowe T; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Tumpey TM; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Katz JM; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Levine MZ; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Lu X; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Pokaż więcej
Źródło :
The Journal of infectious diseases [J Infect Dis] 2017 Sep 15; Vol. 216 (suppl_4), pp. S539-S547.
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Cross Reactions*
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza, Human/*epidemiology
Orthomyxoviridae Infections/*epidemiology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Animals ; Antibodies, Viral/blood ; Antigens, Viral/blood ; Child ; Ferrets/virology ; Hemagglutination Inhibition Tests ; Humans ; Influenza, Human/blood ; Middle Aged ; Orthomyxoviridae Infections/blood ; Prevalence ; Seroepidemiologic Studies ; Swine/virology ; Young Adult
Czasopismo naukowe
Tytuł :
Update: Influenza Activity in the United States During the 2016-17 Season and Composition of the 2017-18 Influenza Vaccine.
Autorzy :
Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Alabi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Mustaquim D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Taylor C; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kramer N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Budd A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garg S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Cummings CN; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Chung J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Flannery B; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Sessions W; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garten R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Elal AIA; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Dugan V; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Burns E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Katz J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jernigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Pokaż więcej
Źródło :
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2017 Jun 30; Vol. 66 (25), pp. 668-676. Date of Electronic Publication: 2017 Jun 30.
Typ publikacji :
Journal Article
MeSH Terms :
Population Surveillance*
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H1N2 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza A Virus, H7N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Coinfection ; Drug Resistance, Viral ; Hospitalization/statistics & numerical data ; Humans ; Infant ; Infant Mortality ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H1N2 Subtype/drug effects ; Influenza A Virus, H1N2 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza A Virus, H7N2 Subtype/drug effects ; Influenza A Virus, H7N2 Subtype/genetics ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza Vaccines/chemistry ; Influenza, Human/mortality ; Influenza, Human/prevention & control ; Influenza, Human/virology ; Middle Aged ; Outpatients/statistics & numerical data ; Pneumonia/mortality ; Seasons ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Update: Influenza Activity - United States, October 2, 2016-February 4, 2017.
Autorzy :
Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Mustaquim D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Alabi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kramer N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Budd A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garg S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Cummings CN; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Bresee J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Sessions W; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garten R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Elal AI; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Burns E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Katz J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jernigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Pokaż więcej
Źródło :
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2017 Feb 17; Vol. 66 (6), pp. 159-166. Date of Electronic Publication: 2017 Feb 17.
Typ publikacji :
Journal Article
MeSH Terms :
Population Surveillance*
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H1N2 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza A Virus, H7N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Antiviral Agents/pharmacology ; Child ; Child Mortality ; Child, Preschool ; Drug Resistance, Viral ; Female ; Hospitalization/statistics & numerical data ; Humans ; Infant ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H1N2 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza, Human/mortality ; Influenza, Human/virology ; Male ; Middle Aged ; Outpatients/statistics & numerical data ; Pneumonia/mortality ; Pregnancy ; Seasons ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Update: Influenza Activity - United States, October 2-December 17, 2016.
Autorzy :
Shang M
Blanton L
Kniss K
Mustaquim D
Alabi N
Barnes S
Budd A
Davlin SL
Kramer N
Garg S
Cummings CN
Flannery B
Fry AM
Grohskopf LA
Olsen SJ
Bresee J
Sessions W
Garten R
Xu X
Elal AI
Gubareva L
Barnes J
Wentworth DE
Burns E
Katz J
Jernigan D
Brammer L
Pokaż więcej
Źródło :
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2016 Dec 30; Vol. 65 (50-51), pp. 1439-1444. Date of Electronic Publication: 2016 Dec 30.
Typ publikacji :
Journal Article
MeSH Terms :
Population Surveillance*
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Ambulatory Care/statistics & numerical data ; Antiviral Agents/pharmacology ; Child ; Child Mortality ; Child, Preschool ; Drug Resistance, Viral ; Hospitalization/statistics & numerical data ; Humans ; Infant ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H1N2 Subtype/isolation & purification ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza, Human/mortality ; Influenza, Human/virology ; Middle Aged ; Pneumonia/mortality ; Seasons ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
A Pyrosequencing-Based Approach to High-Throughput Identification of Influenza A(H3N2) Virus Clades Harboring Antigenic Drift Variants.
Autorzy :
Mishin VP; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Collaborating Center for Surveillance, Epidemiology and Control of Influenza, Atlanta, Georgia, USA.
Baranovich T; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Collaborating Center for Surveillance, Epidemiology and Control of Influenza, Atlanta, Georgia, USA.; Carter Consulting, Inc., Atlanta, Georgia, USA.
Garten R; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Collaborating Center for Surveillance, Epidemiology and Control of Influenza, Atlanta, Georgia, USA.
Chesnokov A; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Collaborating Center for Surveillance, Epidemiology and Control of Influenza, Atlanta, Georgia, USA.; Battelle Memorial Institute, Atlanta, Georgia, USA.
Abd Elal AI; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Collaborating Center for Surveillance, Epidemiology and Control of Influenza, Atlanta, Georgia, USA.; Battelle Memorial Institute, Atlanta, Georgia, USA.
Adamczyk M; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Collaborating Center for Surveillance, Epidemiology and Control of Influenza, Atlanta, Georgia, USA.; Battelle Memorial Institute, Atlanta, Georgia, USA.
LaPlante J; Wadsworth Center, New York State Department of Health (NYSDOH), Albany, New York, USA.
St George K; Wadsworth Center, New York State Department of Health (NYSDOH), Albany, New York, USA.
Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Collaborating Center for Surveillance, Epidemiology and Control of Influenza, Atlanta, Georgia, USA.
Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Collaborating Center for Surveillance, Epidemiology and Control of Influenza, Atlanta, Georgia, USA.
Chester SC; Association of Public Health Laboratories, Silver Spring, Maryland, USA.
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Collaborating Center for Surveillance, Epidemiology and Control of Influenza, Atlanta, Georgia, USA.
Katz JM; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Collaborating Center for Surveillance, Epidemiology and Control of Influenza, Atlanta, Georgia, USA.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Collaborating Center for Surveillance, Epidemiology and Control of Influenza, Atlanta, Georgia, USA.
Gubareva LV; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Collaborating Center for Surveillance, Epidemiology and Control of Influenza, Atlanta, Georgia, USA .
Pokaż więcej
Źródło :
Journal of clinical microbiology [J Clin Microbiol] 2016 Dec 28; Vol. 55 (1), pp. 145-154. Date of Electronic Publication: 2016 Dec 28 (Print Publication: 2017).
Typ publikacji :
Evaluation Study; Journal Article
MeSH Terms :
Genetic Drift*
High-Throughput Nucleotide Sequencing*
Genotyping Techniques/*methods
Influenza A Virus, H3N2 Subtype/*classification
Influenza A Virus, H3N2 Subtype/*genetics
Influenza, Human/*virology
Hemagglutinin Glycoproteins, Influenza Virus/genetics ; Humans ; Influenza A Virus, H3N2 Subtype/isolation & purification ; Polymorphism, Single Nucleotide ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015.
Autorzy :
Flannery B; Influenza Division, Centers for Disease Control and Prevention.
Zimmerman RK; University of Pittsburgh Schools of Health Sciences, Pennsylvania.
Gubareva LV; Influenza Division, Centers for Disease Control and Prevention.
Garten RJ; Influenza Division, Centers for Disease Control and Prevention.
Chung JR; Influenza Division, Centers for Disease Control and Prevention Atlanta Research and Education Foundation, Georgia.
Nowalk MP; University of Pittsburgh Schools of Health Sciences, Pennsylvania.
Jackson ML; Group Health Research Institute, Seattle, Washington.
Jackson LA; Group Health Research Institute, Seattle, Washington.
Monto AS; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor.
Ohmit SE; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor.
Belongia EA; Marshfield Clinic Research Foundation, Wisconsin.
McLean HQ; Marshfield Clinic Research Foundation, Wisconsin.
Gaglani M; Baylor Scott & White Health, Texas A&M Health Science Center College of Medicine, Temple.
Piedra PA; Department of Molecular Virology and Microbiology, and Pediatrics, Baylor College of Medicine, Houston, Texas.
Mishin VP; Influenza Division, Centers for Disease Control and Prevention.
Chesnokov AP; Influenza Division, Centers for Disease Control and Prevention.
Spencer S; Influenza Division, Centers for Disease Control and Prevention Atlanta Research and Education Foundation, Georgia.
Thaker SN; Influenza Division, Centers for Disease Control and Prevention.
Barnes JR; Influenza Division, Centers for Disease Control and Prevention.
Foust A; Influenza Division, Centers for Disease Control and Prevention.
Sessions W; Influenza Division, Centers for Disease Control and Prevention.
Xu X; Influenza Division, Centers for Disease Control and Prevention.
Katz J; Influenza Division, Centers for Disease Control and Prevention.
Fry AM; Influenza Division, Centers for Disease Control and Prevention.
Pokaż więcej
Źródło :
The Journal of infectious diseases [J Infect Dis] 2016 Oct 01; Vol. 214 (7), pp. 1010-9. Date of Electronic Publication: 2016 May 06.
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Genetic Variation*
Influenza A Virus, H3N2 Subtype/*genetics
Influenza A Virus, H3N2 Subtype/*immunology
Influenza Vaccines/*immunology
Influenza, Human/*prevention & control
Influenza, Human/*virology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child, Preschool ; Female ; Genetic Drift ; Hemagglutinin Glycoproteins, Influenza Virus/genetics ; High-Throughput Nucleotide Sequencing ; Humans ; Infant ; Influenza A Virus, H3N2 Subtype/classification ; Influenza Vaccines/administration & dosage ; Male ; Middle Aged ; Treatment Outcome ; United States ; Young Adult
Czasopismo naukowe
Tytuł :
Influenza Activity - United States, 2015-16 Season and Composition of the 2016-17 Influenza Vaccine.
Autorzy :
Davlin SL
Blanton L
Kniss K
Mustaquim D
Smith S
Kramer N
Cohen J
Cummings CN
Garg S
Flannery B
Fry AM
Grohskopf LA
Bresee J
Wallis T
Sessions W
Garten R
Xu X
Elal AI
Gubareva L
Barnes J
Wentworth DE
Burns E
Katz J
Jernigan D
Brammer L
Pokaż więcej
Źródło :
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2016 Jun 10; Vol. 65 (22), pp. 567-75. Date of Electronic Publication: 2016 Jun 10.
Typ publikacji :
Journal Article
MeSH Terms :
Population Surveillance*
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Child ; Child Mortality ; Child, Preschool ; Drug Resistance, Viral ; Hospitalization/statistics & numerical data ; Humans ; Infant ; Infant Mortality ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza Vaccines/chemistry ; Influenza, Human/mortality ; Influenza, Human/prevention & control ; Influenza, Human/virology ; Middle Aged ; Outpatients/statistics & numerical data ; Pneumonia/mortality ; Seasons ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Selection of antigenically advanced variants of seasonal influenza viruses.
Autorzy :
Li C; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
Hatta M; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
Burke DF; Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK.; World Health Organization Collaborating Centre for Modeling, Evolution, and Control of Emerging Infectious Diseases, Cambridge CB2 3EJ, UK.
Ping J; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
Zhang Y; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
Ozawa M; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.; Department of Special Pathogens, International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan.
Taft AS; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
Das SC; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
Hanson AP; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
Song J; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
Imai M; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.; Department of Veterinary Medicine, Faculty of Agriculture, Iwate University, Iwate 020-8550, Japan.
Wilker PR; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
Watanabe T; ERATO Infection-Induced Host Responses Project, Saitama 332-0012, Japan.
Watanabe S; ERATO Infection-Induced Host Responses Project, Saitama 332-0012, Japan.
Ito M; Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan.
Iwatsuki-Horimoto K; Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan.
Russell CA; World Health Organization Collaborating Centre for Modeling, Evolution, and Control of Emerging Infectious Diseases, Cambridge CB2 3EJ, UK.; Fogarty International Center, National Institutes of Health, Bethesda, MD 20892, USA.; Department of Veterinary Medicine, University of Cambridge, Cambridge CB3 0ES, UK.
James SL; Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK.; World Health Organization Collaborating Centre for Modeling, Evolution, and Control of Emerging Infectious Diseases, Cambridge CB2 3EJ, UK.
Skepner E; Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK.; World Health Organization Collaborating Centre for Modeling, Evolution, and Control of Emerging Infectious Diseases, Cambridge CB2 3EJ, UK.
Maher EA; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
Neumann G; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
Klimov AI; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30033, USA.
Kelso A; WHO Collaborating Centre for Reference and Research on Influenza (VIDRL) at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia.
McCauley J; Division of Virology, MRC National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, United Kingdom.
Wang D; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Shu Y; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Odagiri T; Influenza Virus Research Center, National Institute of Infectious Diseases, Musashi-Murayama, Tokyo 208-0011, Japan.
Tashiro M; Influenza Virus Research Center, National Institute of Infectious Diseases, Musashi-Murayama, Tokyo 208-0011, Japan.
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30033, USA.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30033, USA.
Katz JM; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30033, USA.
Cox NJ; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30033, USA.
Smith DJ; Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK.; World Health Organization Collaborating Centre for Modeling, Evolution, and Control of Emerging Infectious Diseases, Cambridge CB2 3EJ, UK.; Department of Virology, Erasmus Medical Center, 3000 CA Rotterdam, Netherlands.
Kawaoka Y; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.; Department of Special Pathogens, International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan.; ERATO Infection-Induced Host Responses Project, Saitama 332-0012, Japan.; Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan.
Pokaż więcej
Źródło :
Nature microbiology [Nat Microbiol] 2016 May 23; Vol. 1 (6), pp. 16058. Date of Electronic Publication: 2016 May 23.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Antigenic Variation*
Antigens, Viral/*genetics
Influenza A Virus, H1N1 Subtype/*genetics
Influenza A Virus, H1N1 Subtype/*immunology
Influenza A Virus, H3N2 Subtype/*genetics
Influenza A Virus, H3N2 Subtype/*immunology
Influenza, Human/*prevention & control
Amino Acid Substitution ; Animals ; Antigens, Viral/immunology ; Evolution, Molecular ; Ferrets/immunology ; Hemagglutinin Glycoproteins, Influenza Virus/chemistry ; Hemagglutinin Glycoproteins, Influenza Virus/genetics ; Hemagglutinin Glycoproteins, Influenza Virus/immunology ; Humans ; Immune Evasion ; Influenza Vaccines/genetics ; Influenza Vaccines/immunology ; Influenza, Human/epidemiology ; Mice ; Orthomyxoviridae Infections/prevention & control ; Seasons
Czasopismo naukowe
Tytuł :
Update: Influenza Activity--United States and Worldwide, May 24-September 5, 2015.
Autorzy :
Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kniss K
Smith S
Mustaquim D
Steffens C
Flannery B
Fry AM
Bresee J
Wallis T
Garten R
Xu X
Elal AI
Gubareva L
Wentworth DE
Burns E
Katz J
Jernigan D
Brammer L
Pokaż więcej
Źródło :
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2015 Sep 18; Vol. 64 (36), pp. 1011-6. Date of Electronic Publication: 2015 Sep 18.
Typ publikacji :
Journal Article
MeSH Terms :
Population Surveillance*
Global Health/*statistics & numerical data
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Humans ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/genetics ; Seasons ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Application of a seven-target pyrosequencing assay to improve the detection of neuraminidase inhibitor-resistant Influenza A(H3N2) viruses.
Autorzy :
Tamura D; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee, USA.
Okomo-Adhiambo M; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Mishin VP; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Guo Z; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Villanueva J; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Stevens J; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Gubareva LV; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA .
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2015 Apr; Vol. 59 (4), pp. 2374-9. Date of Electronic Publication: 2015 Feb 02.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiviral Agents/*pharmacology
Enzyme Inhibitors/*pharmacology
Influenza A Virus, H3N2 Subtype/*drug effects
Neuraminidase/*antagonists & inhibitors
Aged ; Drug Resistance, Viral ; Humans ; Infant ; Influenza A Virus, H3N2 Subtype/enzymology ; Influenza, Human/drug therapy ; Influenza, Human/virology ; Male ; Middle Aged ; Public Health Surveillance ; Recombinant Proteins/chemistry ; Sequence Analysis
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies